STAA STAAR Surgical Company
Company Analysis
Latest News
🟢 STAAR Surgical is trading 5% up today after reporting third-quarter results
STAAR Surgical is trading 5.48% up at $27.58 after reporting third-quarter results. - Revenue was $83.4 million; excluding an unusual prior-year China revenue...
🟢 STAAR Surgical is trading 11.78% up in pre-market after adjusted earnings and revenue beat estimates
STAAR Surgical is trading at $30.37, up 11.78% in pre-market after adjusted earnings and revenue exceeded analyst expectations. - Third-quarter sales were...
STAAR Surgical Beats Estimates as China Fog Clears, but Can the Rally Stick Without Real Growth?
Shares of STAAR Surgical surged 11.4% in after-hours trading to $30.26 after the maker of implantable lenses for vision correction posted third-quarter results...
🟢 STAAR Surgical is trading 11.4% up in after-hours trading after third-quarter results beat expectations
STAAR Surgical is trading at $30.26, up 11.37% in after-hours trading on November 4, 2026, following third-quarter results that beat expectations. - Revenue...
STAAR Surgical beats third quarter 2026 expectations with $83.4M revenue and robust EMEA growth
STAAR Surgical reported third quarter 2026 results that exceeded analyst expectations for both revenue and earnings. Although reported net sales declined 12%...
🟢 STAAR Surgical is trading 7.1% up today ahead of third-quarter results
STAAR Surgical is trading 7.1% higher at $26.85 on November 4, 2026, ahead of its scheduled third-quarter results after the market close. - The company’s...
🟢 STAAR Surgical is trading 10% up in pre-market — no confirmed catalyst
STAAR Surgical is trading at $27.50, up 10.26% pre-market, with no verified catalyst. - Third-quarter 2026 results are scheduled after market close on...
STAAR Surgical Company Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026
Analysts expect STAAR Surgical to report Q3 2026 revenue of $78.73 million and EPS of $0.05, with the current $24.54 stock price trading at an 11% discount to...
🔴 STAAR Surgical is trading 5% down in pre-market without a clear company-specific catalyst
STAAR Surgical is trading at $22.00, down 5.29% in pre-market on October 27, 2026, with no clear company-specific catalyst identified. - The latest company...
🔴 STAAR Surgical is trading 5% down today amid inflation and rate concerns
STAAR Surgical is trading 5.03% down at $21.14 on October 16, 2026, with broader market pressures a plausible context, not a confirmed company-specific...
🟢 STAAR Surgical is trading 5.6% up in pre-market after Wall Street Zen upgraded shares to Buy
STAAR Surgical is trading 5.63% up at $23.25 in pre-market on October 13 after Wall Street Zen reportedly upgraded the shares from Hold to Buy in a report...
🔴 STAAR Surgical is trading 5% down in pre-market on October 5, 2026
STAAR Surgical is trading at $21.32, with a -5.12% change before the October 5 session; the catalyst remains unclear. - The latest identifiable...
🟢 STAAR Surgical is trading 6.9% up today after Stifel upgraded it to Buy
STAAR Surgical is trading 6.9% up at $22.30 on September 29, following Stifel’s upgrade from Hold to Buy and price-target increase from $28 to $31, a plausible...
🟢 STAAR Surgical is trading 6% up in pre-market after Stifel’s Buy upgrade
STAAR Surgical is trading at $22.10, up 5.89% in pre-market; Stifel’s upgrade is a potential catalyst, though its role is unconfirmed. - On September 28,...
🟢 STAAR Surgical is trading 5.5% up today after authorizing up to $50 million in buybacks
STAAR Surgical is trading 5.5% higher at $20.12 after announcing a share repurchase authorization of up to $50 million. - The program was authorized on...
🔴 STAAR Surgical is trading 5.3% down today with no clear company-specific catalyst
STAAR Surgical is trading 5.3% down at $21.22, with no reliable company-specific catalyst identified. - No reliable September 17, 2026 company-specific...
🟢 STAAR Surgical is trading 7% up in pre-market with no clear catalyst identified
STAAR Surgical is trading 6.93% up at $24.00, with no clearly identified company-specific catalyst for September 16, 2026. - Investor attention has centered...
🔴 STAAR Surgical is trading 5% down today
STAAR Surgical is trading 5.12% down at $22.22, despite the broader market advancing on September 11, 2026; no reliable source identified a fresh...
STAAR Surgical Appoints Former CEO David Bailey as New Chief Commercial Officer
STAAR Surgical Company announced the appointment of David Bailey as its new Chief Commercial Officer, effective September 8, 2026. Mr. Bailey is a returning...
STAAR Surgical Appoints New CTO, Driving Multi-Product Platform Strategy
STAAR Surgical Company appointed Ben Park, Ph.D., as Chief Technology Officer. Park joins the executive committee and reports to President and CEO Warren...